The United Laboratories International Holdings Limited
Research The United Laboratories International Holdings Limited (UNJ) on Bullrun: market cap EUR 1.83B, P/E 6.6, dividend yield 5.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUNJ
- ExchangeF
- CountryHong Kong
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 1.83B
- P/E6.6
- Dividend yield5.7%
- Financial periodFY2025
- RevenueCNY 13.21B
- Revenue growth-4.0%
- Net incomeCNY 2.09B
- Free cash flowCNY 855.45M
- Gross margin41.7%
Valuation Snapshot
latest market cap is EUR 1.83B; P/E is 6.6; dividend yield is 5.7%.
Peer valuation comparison
Latest P/E is 6.64x versus a Healthcare sector median of 24.46x (72.8% below).
Latest dividend yield is 5.72% versus a Healthcare sector median of 2.11% (171.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 13.21B | CNY 2.09B | CNY 855.45M | 41.7% | 1.11 | CNY 10.61B | CNY 4.99B | CNY 17.39B |
| FY2024 | CNY 13.76B | CNY 2.66B | CNY 1.33B | 44.2% | 1.46 | CNY 6.33B | CNY 3.16B | CNY 14.39B |
| FY2023 | CNY 13.74B | CNY 2.70B | CNY 977.50M | 46.1% | 1.49 | CNY 4.26B | CNY 1.50B | CNY 12.73B |
| FY2022 | CNY 11.33B | CNY 1.58B | CNY 1.21B | 43.8% | 0.87 | CNY 4.74B | CNY 2.46B | CNY 10.61B |
| FY2021 | CNY 9.70B | CNY 988.10M | CNY 1.06B | 43.4% | 0.54 | CNY 3.33B | CNY 1.84B | CNY 9.34B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 1.83B | 6.6 | 5.7% | 0.05 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.05 EUR, yield 5.7%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.07 CNY |
| FY2024 | 0.07 CNY |
| FY2023 | 0.04 CNY |
| FY2022 | 0.02 CNY |
| FY2021 | 0.02 CNY |
About The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is The United Laboratories International Holdings Limited's market cap?
The United Laboratories International Holdings Limited's market capitalization is EUR 1.83B.
What is The United Laboratories International Holdings Limited's P/E ratio?
The United Laboratories International Holdings Limited's price-to-earnings (P/E) ratio is 6.6.
Does The United Laboratories International Holdings Limited pay a dividend?
The United Laboratories International Holdings Limited has a dividend yield of 5.7%.
What does The United Laboratories International Holdings Limited do?
The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products.